首页> 外文期刊>BMC Cancer >Herbal compound 'Songyou Yin' reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice
【24h】

Herbal compound 'Songyou Yin' reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice

机译:中药复方“松油饮”增强α-干扰素抑制裸鼠肝癌姑息性切除所致转移潜力的能力

获取原文
           

摘要

Background Liver resection is a widely accepted treatment for hepatocellular carcinoma (HCC). Our previous clinical study showed that the rate of palliative resection was 34.0% (1958-2008, 2754 of 8107). However, the influence of palliative resection on tumor metastasis remains controversial. The present study was conducted to evaluate the effect of palliative resection on residual HCC and to explore interventional approaches. Methods Palliative resection was done in an orthotopic nude mice model of HCC (MHCC97H) with high metastatic potential. Tumor growth, invasion, metastasis, lifespan, and some molecular alterations were examined in vivo and in vitro. Mice that underwent palliative resection were treated with the Chinese herbal compound "Songyou Yin," interferon-alfa-1b (IFN-α), or their combination to assess their effects. Results In the palliative resection group, the number of lung metastatic nodules increased markedly as compared to the sham operation group (14.3 ± 4.7 versus 8.7 ± 3.6, P 3, 724.9 ± 337.6 mm3, 507.6 ± 367.0 mm3, and 245.3 ± 181.2 mm3 in the control, "Songyou Yin," IFN-α, and combination groups, respectively. The combined therapy noticeably decreased the MMP2/TIMP2 ratio and prolonged the lifespan by 42.2%. Moreover, a significant ( P Conclusion Palliative resection-stimulated HCC metastasis may occur, in part, by up-regulation of VEGF and MMP2/TIMP2. "Songyou Yin" reinforced the ability of IFN-α to inhibit the metastasis-enhancing potential induced by palliative resection, which indicated its potential postoperative use in patients with HCC.
机译:背景技术肝切除术是肝细胞癌(HCC)的一种广泛接受的治疗方法。我们以前的临床研究表明姑息性切除率为34.0%(1958-2008,第2754个,共8107个)。然而,姑息性切除术对肿瘤转移的影响仍存在争议。本研究旨在评估姑息性切除术对残余肝癌的影响并探讨干预方法。方法在具有高转移潜能的原位肝癌裸鼠模型(MHCC97H)中进行姑息性切除。在体内和体外检查了肿瘤的生长,侵袭,转移,寿命和某些分子改变。接受姑息性切除术的小鼠用中草药化合物“松油茵”,干扰素-α-1b(IFN-α)或它们的组合治疗,以评估其效果。结果姑息切除组与假手术组相比,肺转移结节数明显增加(分别为14.3±4.7和8.7±3.6,P 3 ,724.9±337.6mm 3 对照组,“松油茵”,IFN-α和联合治疗组分别为507.6±367.0 mm 3 和245.3±181.2 mm 3 降低MMP2 / TIMP2比率并延长寿命42.2%。此外,显着的(P结论姑息性切除刺激的HCC转移可能部分是由于VEGF和MMP2 / TIMP2的上调引起的。 IFN-α抑制姑息性切除术所致转移增强潜力的能力,表明其在肝癌患者术后的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号